Cargando…
Targeting quiescent leukemic stem cells using second generation autophagy inhibitors
In chronic myeloid leukemia (CML), tyrosine kinase inhibitor (TKI) treatment induces autophagy that promotes survival and TKI-resistance in leukemic stem cells (LSCs). In clinical studies hydroxychloroquine (HCQ), the only clinically approved autophagy inhibitor, does not consistently inhibit autoph...
Autores principales: | Baquero, Pablo, Dawson, Amy, Mukhopadhyay, Arunima, Kuntz, Elodie M., Mitchell, Rebecca, Olivares, Orianne, Ianniciello, Angela, Scott, Mary T., Dunn, Karen, Nicastri, Michael C., Winkler, Jeffrey D., Michie, Alison M., Ryan, Kevin M., Halsey, Christina, Gottlieb, Eyal, Keaney, Erin P., Murphy, Leon O., Amaravadi, Ravi K., Holyoake, Tessa L., Helgason, G. Vignir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292500/ https://www.ncbi.nlm.nih.gov/pubmed/30185934 http://dx.doi.org/10.1038/s41375-018-0252-4 |
Ejemplares similares
-
Targeting mitochondrial oxidative phosphorylation eradicates
therapy-resistant chronic myeloid leukemic stem cells
por: Kuntz, Elodie M., et al.
Publicado: (2017) -
The Ins and Outs of Autophagy and Metabolism in Hematopoietic and Leukemic Stem Cells: Food for Thought
por: Ianniciello, Angela, et al.
Publicado: (2018) -
ATG7 regulates energy metabolism, differentiation and survival of Philadelphia-chromosome-positive cells
por: Karvela, Maria, et al.
Publicado: (2016) -
Pyruvate anaplerosis is a targetable vulnerability in persistent leukaemic stem cells
por: Rattigan, Kevin M., et al.
Publicado: (2023) -
Assembling defenses against therapy-resistant leukemic stem cells: Bcl6 joins the ranks
por: Pellicano, Francesca, et al.
Publicado: (2011)